生命科学资讯

HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic

Morgan Stanley cuts Agilent stock price target on valuation multiples - Investing.com

Waters Corporation (WAT) Investor Outlook: Evaluating A Potential 24.63% Upside - DirectorsTalk Interviews

Thermo Fisher (NYSE: TMO) HR chief disposes shares to cover tax liability - Stock Titan

Major RSU grant to 10x Genomics (TXG) CEO Serge Saxonov - Stock Titan

Two more members added to ACIP ahead of March meeting

Breaking Down 10x Genomics: 11 Analysts Share Their Views - Benzinga

Cullgen ditches reverse merger with Pulmatrix to go with Gyre in $300M buyout

TCE biotech Candid scores Nasdaq listing via reverse merger with rare disease-focused Rallybio

Boehringer axes MASH deal with OSE as biotech continues to whittle down pipeline

Thermo Fisher Scientific: Recovery In Life Sciences Solutions (NYSE:TMO) - Seeking Alpha

Assessing Agilent Technologies (A) Valuation After Recent Share Price Softness and Long Term Gains - Yahoo Finance

Ascendis wins FDA approval of dwarfism drug

Illumina Inc (ILMN) Trading Down 2.84% on Mar 2 - GuruFocus

UniQure says FDA wants another study of Huntington’s gene therapy

Appointments and advancements for March 2, 2026

Financings for March 2, 2026

In the clinic for March 2, 2026

Other news to note for March 2, 2026

Regulatory actions for March 2, 2026